RenovoRx, Inc.

NasdaqCM: RNXT · Healthcare

Positivity Index

#5,608 / 6,774

Global

#3,081 / 4,000

United States

Positivity Score

16,653

Rank→

PosiRed: 2 active red flags (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 02 Jul 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 02 Jan 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

RenovoRx, Inc. — Overview & Financial Snapshot

RenovoRx, Inc. (NasdaqCM: RNXT) is a Healthcare company, ranked #5,608 of 6,774 companies globally and #3,081 of 4,000 in United States on PositoAI, with a Positivity Score of 16,653. Its market capitalisation is ₹541.00 Cr ($57.31M), P/E ratio is -4.1 and P/B ratio is 6.38. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does RenovoRx, Inc. do?

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials…

What is RenovoRx, Inc.'s P/E and P/B ratio?

RenovoRx, Inc. has a P/E ratio of -4.1 and a P/B ratio of 6.38.

What is RenovoRx, Inc.'s debt-to-equity ratio?

RenovoRx, Inc. has a debt-to-equity ratio of 0.04.

How much does RenovoRx, Inc. owe compared with what it owns?

RenovoRx, Inc. owes $0.22 for every $1 it owns (balance sheet Jun 2026), which is low.

What is RenovoRx, Inc.'s Positivity rank?

RenovoRx, Inc. is ranked #5,608 of 6,774 companies globally and #3,081 of 4,000 in United States on PositoAI, with a Positivity Score of 16,653.

Does RenovoRx, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. RenovoRx, Inc. has 2 active red flags (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 02 Jul 2026); Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 02 Jan 2026). It has no yellow flags.

Where can I read the latest news about RenovoRx, Inc.?

Recent headlines about RenovoRx, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does RenovoRx, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of RenovoRx, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.